Vitafoods Europe 2026: Kerry looks to close clinical gap in women’s health nutrition
29 May 2026 | Kerry
Kerry’s R&D director for women and infant health, Monica Maria Olivarez, talked with us about the company’s clinically validated probiotic and botanical ingredient portfolio that targets fertility, menopause, cognitive stress, and sleep. She highlighted the role of science-driven clinical trials and AI-driven research to help identify and address unmet needs in women’s health.
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients















